LRRK2 and Parkinson disease: PARK8, implicated in modulating inflammatory responses and the recruitment of microglia in PD (Rui et al., 2018), tends to heighten its activity during periods of oxidative stress and endolysosomal dysfunction (Rocha et al., 2022).